'America's Nobel' goes to a power couple who made a startling discovery about HIV
Salim and Quarraisha Abdool-Karim transformed the understanding and approach towards HIV/AIDS in young South African women, earning the Lasker Prize for their contributions.
Infected blood scandal: A 'horrifying' global disaster DW 09/02/2024
The UK's infected blood scandal led to thousands infected with HIV/hepatitis due to contaminated blood products and highlighted ongoing injustices from the cover-up.
How HIV/AIDS got its name the words Americans used for the crisis were steeped in science, stigma and religious language
The term 'AIDS' was pivotal in shaping perceptions and stigma surrounding the disease, influencing both public discussion and activism.
Climate Crisis Is Impeding Access to HIV Treatment in High Risk Regions
Half of people with HIV in the U.S. live in areas vulnerable to extreme weather disasters.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
A promising biannual HIV vaccine shows 100% efficacy in women and high effectiveness in men, but access concerns arise in certain regions.
More than half of HIV-positive Americans are 50+. Figuring out care is complex
HIV-positive individuals over 50 require specialized care and awareness as misconceptions about aging and sexual health remain prevalent.
'America's Nobel' goes to a power couple who made a startling discovery about HIV
Salim and Quarraisha Abdool-Karim transformed the understanding and approach towards HIV/AIDS in young South African women, earning the Lasker Prize for their contributions.
Infected blood scandal: A 'horrifying' global disaster DW 09/02/2024
The UK's infected blood scandal led to thousands infected with HIV/hepatitis due to contaminated blood products and highlighted ongoing injustices from the cover-up.
How HIV/AIDS got its name the words Americans used for the crisis were steeped in science, stigma and religious language
The term 'AIDS' was pivotal in shaping perceptions and stigma surrounding the disease, influencing both public discussion and activism.
Climate Crisis Is Impeding Access to HIV Treatment in High Risk Regions
Half of people with HIV in the U.S. live in areas vulnerable to extreme weather disasters.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
A promising biannual HIV vaccine shows 100% efficacy in women and high effectiveness in men, but access concerns arise in certain regions.
More than half of HIV-positive Americans are 50+. Figuring out care is complex
HIV-positive individuals over 50 require specialized care and awareness as misconceptions about aging and sexual health remain prevalent.
Leonilson's art powerfully intertwines personal struggle with broader social critiques, reflecting on life, death, and identity amidst Brazil's political challenges.
HIV+ patients can now receive organs from HIV+ donors
Patients with HIV can now receive organs from HIV-positive donors, easing transplant waiting times and expanding the donor pool.
New Rule Allows HIV-Positive Organ Transplants
People with HIV can now receive organ transplants from HIV-positive donors, increasing the available organ supply and improving patient outcomes.
Court strikes down last barrier to military service by people living with HIV
The court ruling allows asymptomatic HIV-positive individuals with undetectable viral loads to serve in the military, promoting inclusivity and challenging stigma.
Federal government eases rules on organ transplants between donors and recipients with HIV
HHS has relaxed rules on kidney and liver donations between HIV-positive individuals, increasing access to organ transplants for this community.
HIV+ patients can now receive organs from HIV+ donors
Patients with HIV can now receive organs from HIV-positive donors, easing transplant waiting times and expanding the donor pool.
New Rule Allows HIV-Positive Organ Transplants
People with HIV can now receive organ transplants from HIV-positive donors, increasing the available organ supply and improving patient outcomes.
Court strikes down last barrier to military service by people living with HIV
The court ruling allows asymptomatic HIV-positive individuals with undetectable viral loads to serve in the military, promoting inclusivity and challenging stigma.
Federal government eases rules on organ transplants between donors and recipients with HIV
HHS has relaxed rules on kidney and liver donations between HIV-positive individuals, increasing access to organ transplants for this community.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
HIV prophylactic lenacapavir very safe and very expensive DW 11/29/2024
Lenacapavir is a revolutionary antiretroviral drug achieving nearly 100% effectiveness for HIV prevention and treatment with just two injections yearly.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
HIV prophylactic lenacapavir very safe and very expensive DW 11/29/2024
Lenacapavir is a revolutionary antiretroviral drug achieving nearly 100% effectiveness for HIV prevention and treatment with just two injections yearly.
HIV treatment progress in Namibia: Anna's story DW 10/17/2024
HIV stigma and isolation persist despite advancements in treatment, as illustrated by personal experiences of those diagnosed.
Multimodal Artificial Intelligence: Opportunities and Challenges in HIV Clinical Care
The goal of this concept is to encourage the use of multimodal artificial intelligence to accelerate HIV diagnosis, prevention, and treatment.
The concept aims to leverage advanced multimodal AI models to improve HIV prevention, treatment, and care by expanding capacities in clinical care and data-driven applications.
HIV treatment progress in Namibia: Anna's story DW 10/17/2024
HIV stigma and isolation persist despite advancements in treatment, as illustrated by personal experiences of those diagnosed.
Multimodal Artificial Intelligence: Opportunities and Challenges in HIV Clinical Care
The goal of this concept is to encourage the use of multimodal artificial intelligence to accelerate HIV diagnosis, prevention, and treatment.
The concept aims to leverage advanced multimodal AI models to improve HIV prevention, treatment, and care by expanding capacities in clinical care and data-driven applications.
Fauci reflects on life's work with leading SF researcher
Havlir and Fauci's HIV experience prepared them for the Covid pandemic
Treatment Strategies for CNS Complications in People with HIV
Identify modifiable targets and mechanisms to improve CNS-related outcomes in individuals with HIV, enhancing their quality of life and functional capacity.
Fauci reflects on life's work with leading SF researcher
Havlir and Fauci's HIV experience prepared them for the Covid pandemic
Treatment Strategies for CNS Complications in People with HIV
Identify modifiable targets and mechanisms to improve CNS-related outcomes in individuals with HIV, enhancing their quality of life and functional capacity.
People with HIV are aging, and the challenges are piling up
Aging with HIV comes with increased health risks and challenges, including managing multiple health conditions.
Blood scandal victim's wife told to have abortion after he was infected with HIV
The contaminated blood scandal has caused devastating consequences for victims and their families, impacting their ability to conceive and obtain fair compensation.
Ukraine keeps up the fight against HIV while fighting a war
War in Ukraine risks reversing progress against HIV due to healthcare disruptions and increased displacement of populations.
The CDC finds discrimination puts trans women at higher risk of HIV
Discrimination puts trans women at higher risk of contracting HIV.
Trans women need improved access to healthcare and PrEP.
People with HIV are aging, and the challenges are piling up
Aging with HIV comes with increased health risks and challenges, including managing multiple health conditions.
Blood scandal victim's wife told to have abortion after he was infected with HIV
The contaminated blood scandal has caused devastating consequences for victims and their families, impacting their ability to conceive and obtain fair compensation.
Ukraine keeps up the fight against HIV while fighting a war
War in Ukraine risks reversing progress against HIV due to healthcare disruptions and increased displacement of populations.
The CDC finds discrimination puts trans women at higher risk of HIV
Discrimination puts trans women at higher risk of contracting HIV.
Trans women need improved access to healthcare and PrEP.
I wasn't sure I'd make it': how a new mother's brush with TB could mean better treatment for pregnant women
Access to effective healthcare regimens for drug-resistant tuberculosis during pregnancy is severely lacking, impacting both maternal and infant health.
Engineered Virus Steals Proteins From H.I.V., Pointing to New Therapy
A new therapeutic approach using a molecular mimic to combat H.I.V. by stealing essential proteins from the virus and preventing it from multiplying.
Get Your Free 2024 Mpox Vaccine, Say San Francisco Health Officials | KQED
Communities at risk of mpox include gay, bisexual, MSM, trans, nonbinary individuals, and those with HIV or on PrEP.
PEPFAR has saved 25 million lives, treated 20 million people with HIV, and prevented 5.5 million babies from being born with HIV in the past twenty years.
Global challenges such as the rising cost of living, conflicts, and the climate crisis are threatening the funding and support for programs like PEPFAR.
STIs Are Increasing In Many Regions, New WHO Report Finds
HIV, viral hepatitis, and STIs are causing significant global health burdens, with many infections and deaths each year.
Global response efforts are falling short of meeting targets set in 2022 to end AIDS, viral hepatitis, and STIs epidemics by 2030.
A beacon in the fight against HIV
PEPFAR has saved 25 million lives, treated 20 million people with HIV, and prevented 5.5 million babies from being born with HIV in the past twenty years.
Global challenges such as the rising cost of living, conflicts, and the climate crisis are threatening the funding and support for programs like PEPFAR.
STIs Are Increasing In Many Regions, New WHO Report Finds
HIV, viral hepatitis, and STIs are causing significant global health burdens, with many infections and deaths each year.
Global response efforts are falling short of meeting targets set in 2022 to end AIDS, viral hepatitis, and STIs epidemics by 2030.
10 million Brits would not work or be friends with someone HIV+
10 million Brits would avoid being friends with or working with someone who was HIV+.
Many Brits are still ignorant of how HIV can be transmitted.
Watch: Can opt-out HIV tests help end new cases?
Over 3,500 previously undiagnosed cases of HIV, Hepatitis B, and Hepatitis C have been identified through opt-out testing pilots in the UK since April 2022.
The trials aimed to identify cases in people who are unlikely to get tested at a sexual health clinic.
Opt-out testing can lead to early diagnosis and save the NHS money in the long term.
8 Common HIV Myths You Need To Stop Believing
Misinformation and stigma surrounding HIV and AIDS have led to underdiagnosis and undertreatment.
Education is important in dispelling myths and reducing the stigma around HIV.
Study says people over 40 with HIV would benefit from also taking this medication
The British HIV Association recommends that everyone over 40 living with HIV should be offered statins for the primary prevention of cardiovascular disease, regardless of their cholesterol levels.
The recommendations are based on the findings of the REPRIEVE study, which showed that participants assigned statins had a significantly lower risk of developing major cardiovascular problems.
Latinos disproportionately impacted by HIV in Santa Clara Co., data shows
Despite progress made against HIV and AIDS, 35,000 people still become infected in the US each year.
Racial inequities in HIV diagnoses persist, with 60% of new diagnoses in Santa Clara County occurring among the Hispanic and Latino community.
HIV vaccine trial in Africa halted after disappointing initial results
The first trial in Africa testing two combination vaccines to prevent HIV has been halted after researchers determined that the vaccines were not effective.
The trial, known as the PrEPVacc trial, was being conducted on 1,500 people aged 18 to 40 in Uganda, Tanzania, and South Africa.
The final results of the trial are expected to be released in late 2024.
10 million Brits would not work or be friends with someone HIV+
10 million Brits would avoid being friends with or working with someone who was HIV+.
Many Brits are still ignorant of how HIV can be transmitted.
Watch: Can opt-out HIV tests help end new cases?
Over 3,500 previously undiagnosed cases of HIV, Hepatitis B, and Hepatitis C have been identified through opt-out testing pilots in the UK since April 2022.
The trials aimed to identify cases in people who are unlikely to get tested at a sexual health clinic.
Opt-out testing can lead to early diagnosis and save the NHS money in the long term.
8 Common HIV Myths You Need To Stop Believing
Misinformation and stigma surrounding HIV and AIDS have led to underdiagnosis and undertreatment.
Education is important in dispelling myths and reducing the stigma around HIV.
Study says people over 40 with HIV would benefit from also taking this medication
The British HIV Association recommends that everyone over 40 living with HIV should be offered statins for the primary prevention of cardiovascular disease, regardless of their cholesterol levels.
The recommendations are based on the findings of the REPRIEVE study, which showed that participants assigned statins had a significantly lower risk of developing major cardiovascular problems.
Latinos disproportionately impacted by HIV in Santa Clara Co., data shows
Despite progress made against HIV and AIDS, 35,000 people still become infected in the US each year.
Racial inequities in HIV diagnoses persist, with 60% of new diagnoses in Santa Clara County occurring among the Hispanic and Latino community.
HIV vaccine trial in Africa halted after disappointing initial results
The first trial in Africa testing two combination vaccines to prevent HIV has been halted after researchers determined that the vaccines were not effective.
The trial, known as the PrEPVacc trial, was being conducted on 1,500 people aged 18 to 40 in Uganda, Tanzania, and South Africa.
The final results of the trial are expected to be released in late 2024.
Virologists making progress in fight against HIV/AIDS DW 12/01/2023
Antiretroviral drugs have been successful in treating HIV infection since the mid-1990s.
Integrase inhibitors are a major breakthrough in HIV treatment and have saved the lives of many patients.
The Hidden Cost of a "Cure": The Ethical Dilemma of Gene Editing for HIV - Non Profit News | Nonprofit Quarterly
Gene editing, particularly CRISPR technology, offers a promising avenue to potentially eradicate HIV by making targeted edits at a cellular level.
The enigma of elite HIV controllers: The people with an innate ability to keep the virus at bay
Elite controllers of HIV virus show natural ability to control the infection without medication, offering potential for scientific breakthroughs and pursuit of a functional cure.